Valmark Advisers, Inc. Eli Lilly & CO Transaction History

Valmark Advisers, Inc.

$6.34 Billion
Q3 2024

A detailed history of Valmark Advisers, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Valmark Advisers, Inc. holds 5,980 shares of LLY stock, worth $4.57 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

5,980

Previous 5,736 4.25%

Holding current value

$4.57 Million

Previous $5.19 Million 2.0%

% of portfolio

0.08%

Previous 0.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$772.14 - $960.02 $188,402 - $234,244	244 Added 4.25%	5,980 $5.3 Million
Q2 2024 Jul 31, 2024	BUY	$724.87 - $909.04 $105,831 - $132,719	146 Added 2.61%	5,736 $5.19 Million
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $620,033 - $829,517	1,047 Added 23.05%	5,590 $4.35 Million
Q4 2023 Feb 02, 2024	BUY	$525.19 - $619.13 $36,238 - $42,719	69 Added 1.54%	4,543 $2.65 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $1,738 - $2,397	4 Added 0.09%	4,474 $2.4 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $55,066 - $73,629	-157 Reduced 3.39%	4,470 $2.1 Million
Q1 2023 May 01, 2023	SELL	$310.63 - $364.82 $4,970 - $5,837	-16 Reduced 0.34%	4,627 $1.59 Million
Q4 2022 Feb 06, 2023	SELL	$321.55 - $374.67 $248,558 - $289,619	-773 Reduced 14.27%	4,643 $1.7 Million
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $45,954 - $52,369	155 Added 2.95%	5,416 $1.75 Million
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $71,076 - $83,453	-255 Reduced 4.62%	5,261 $1.71 Million
Q1 2022 May 10, 2022	BUY	$234.69 - $291.66 $102,324 - $127,163	436 Added 8.58%	5,516 $1.58 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $328,955 - $408,235	1,463 Added 40.45%	5,080 $1.4 Million
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $2,659 - $3,272	12 Added 0.33%	3,617 $836,000
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $8,124 - $10,509	45 Added 1.26%	3,605 $827,000
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $68,357 - $88,491	416 Added 13.23%	3,560 $665,000
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $26,613 - $35,216	204 Added 6.94%	3,144 $531,000
Q3 2020 Nov 09, 2020	SELL	$146.22 - $169.13 $2,778 - $3,213	-19 Reduced 0.64%	2,940 $435,000
Q2 2020 Jul 31, 2020	BUY	$136.42 - $164.18 $54,431 - $65,507	399 Added 15.59%	2,959 $486,000
Q1 2020 May 01, 2020	BUY	$119.05 - $147.35 $49,286 - $61,002	414 Added 19.29%	2,560 $355,000
Q4 2019 Jan 31, 2020	BUY	$106.92 - $132.43 $5,559 - $6,886	52 Added 2.48%	2,146 $282,000
Q3 2019 Nov 06, 2019	BUY	$106.79 - $116.16 $15,057 - $16,378	141 Added 7.22%	2,094 $234,000
Q2 2019 Aug 07, 2019	SELL	$110.79 - $129.32 $24,595 - $28,709	-222 Reduced 10.21%	1,953 $216,000
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $11,464 - $13,495	103 Added 4.97%	2,175 $282,000
Q4 2018 Feb 07, 2019	BUY	$105.9 - $118.64 $219,424 - $245,822	2,072 New	2,072 $240,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $727B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valmark Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valmark Advisers, Inc. with notifications on news.

Account

Valmark Advisers, Inc. Eli Lilly & CO Transaction History